Singulair - News Articles

Asthma and Allergy Patients Prescribed Montelukast Instead of First Line Therapy and Shows Low Rate of Persistence


“Patients with asthma or allergic rhinitis (nasal allergies), initially prescribed montelukast (Singulair) instead of typical first-line therapy have low rates of persistence on montelukast and may ultimately discontinue therapy altogether, according to a new study presented at the Academy of Managed Care Pharmacy’s 23rd Annual Meeting in Minneapolis, Minnesota. ...
logowanie - esculap


The current GINA and PRACTALL guidelines on asthma treatment and ARIA recommendations classify montelukast as a drug controlling the course of the disease. The effectiveness and safety of pharmacotherapy in allergology depends to a large extent on the ...
Canadian Pharmacy – Very Big Drug Price Differences Among Online Drug Companies Reported | Star Global Tribune


A Consumer Reports study recently compared prices between various American pharmacies of at least four popular prescription drugs including, Lipitor, Nexium, Plavix, and Singulair and the American online pharmacy that believes it has the lowest total price on these products issued a press release noting that their prices beat at least one of their higher ...
Optimizing Drug Benefit Plan Designs for the Coming Wave of Generic Competition | AIS Health


And next year, patents are scheduled to run out on the blood clot inhibitor Plavix (clopidogrel); the asthma drug Singulair (montelukast); Concerta (methylphenidate), a drug for attention-deficit hyperactivity disorder; and the antipsychotics Seroquel (quetiapine) and Zyprexa (olanzapine), to name just a few. Join us on May 17 and hear two pharmacy management ...
Canadian Pharmacy’s Online Drugs the Solution to Americans Unable to Buy Medications - Education News - redOrbit


In fact, the recent NorthWestPharmacy.com “Canadian Online Pharmacy Survey” found that an American buying from its website could save more than $5600 per year on brand name Lipitor 20mg, Plavix 75mg, Nexium 40mg and Singulair 10mg through Canadian drugs and international medicines versus leading American online pharmacies. Canadian pharmacies are often less expensive than American online pharmacies ...
6 Stocks Whose Earnings Are Expected to Increase Sharply - Seeking Alpha


Singulair, the company's highest grossing drug at $4.99 billion in 2010 expires in 2012. Crixivan, Maxalt, Cancidas and Propecia also expire by 2013. The drugs expiring in 2012 and 2013 contributed $6.8 billion of the company's $45.98 billion in 2010 sales. Despite the expirations, the company sports a strong pipeline of drugs in Phase II, Phase III and under ...
Generic Drugs Took Market Share From Branded Products At Faster Pace In 2010 | Markets | Minyanville.com


Only three branded drugs were among the most-prescribed products in the US last year: cholesterol treatment Lipitor, the blood thinner Plavix and asthma medicine Singulair. The most prescribed drug in the US last year was the generic version of the narcotic Vicodin. The No. 2 most prescribed medicine was the generic Zocor cholesterol drug, followed by the high blood ...
logowanie - esculap


U pacjentów z rozpoznana astma oskrzelowa i przewleklym niezytem nosa mozna podac montelukast, który zastosowany lacznie z niesedatywnym lekiem przeciwhistaminowym moze byc w wielu sytuacjach tak skuteczny jak donosowe glikokortykosteroidy (14). ...
Rising Star Buy: Medco Health (MHS)


Starting in December of this year through the end of 2012, approximately $35 billion worth of sales more will lose patent exclusivity, including Lipitor, Plavix, and Singulair. One industry positioned to profit from the wave of new generic launches is the pharmacy benefits managers or PBMs. Born in the 1980s, PBMs work for health-care payors such as insurance companies, ...
Caring for patients with asthma


Montelukast (Singulair) and zafirlukast (Accolade) block the actions of leukotrienes which cause bronchoconstriction, hyper-responsiveness and increased mucous production 3 . Chronic asthma treatment is determined by the patient's disease severity and ...
Buyers Stepping In - Merck | Tech-Corner- TradersHuddle.com


Merck's products include Zocor for treatment of elevated cholesterol, Propecia for treatment for male pattern hair loss, Fosamax for preventive treatment of osteoporosis, and Singulair for treatment of asthma. Merck was founded in 1891 and is headquartered in Whitehouse Station, New Jersey. Merck has already traded 1.003 times its 3-month average volume, and has calculated ...
The Pickens Sentinel - More Generics Mean Lower Drug Prices


Drugs set to expire this year and next include: Lipitor (expired in November 2010, generic due this year), Seroquel, Avandia, Lunesta and Singulair. Just before a patent expires, drug companies will renew their efforts to get doctors to prescribe their product. When your doctor prescribes something for you, ask if it's one of the drugs that has come off ...
9 Healthcare Sector Rotation Buy Ideas - Seeking Alpha


Merck lost patent protection on two of its major drugs in 2010, Cozaar and Hyzaar, and the upcoming patent loss in 2012 on Singulair, which makes up over 10% of Merck' sales, will cause Merck to lose one of its main sources of revenue. The company has no reliable late-stage drugs in the pipeline to offset the loss; four of Merck’s late-stage drugs ...
Many treatments for allergic rhinitis - Columns


Finally, Singulair (montelukast sodium) can block leukotriene effects and relieve allergic symptoms, but not as effectively as corticosteroid nasal sprays. However, because Singulair is in pill form, it can also be used to treat mild asthma and is therefore a good choice for patients with mild allergic rhinitis and asthma. Dr. Yong H. Tsai is board-certified in ...
Heuschnupfen plus Husten: Asthmaalarm


"Daher sollte lediglich während der Pollensaison täglich ein niedrigdosiertes Kortikosteroid inhaliert oder der Leukotrien-Antagonist Montelukast eingenommen werden", empfiehlt Professor Karl-Christian Bergmann vom Allergie-Centrum-Charité in Berlin. ...
MonoSol Rx receives positive FDA feedback for Montelukast Sodium OSF - Pharmaceutical Business Review


MonoSol Rx president and CEO Mark Schobel said they are pleased with the positive FDA feedback on the 505(b) (2) pathway for Montelukast Sodium OSF, which has demonstrated positive results in pilot bioequivalence studies when compared to Singulair. "The OSF formulation also delivers an easy-to-take, taste-masked option for children taking the chewable tablets," Schobel said. Share: Related ...
AARP NEWS: Some brand-name drug prices are increasing | Daily Record | dailyrecord.com


Lescol XL (high cholesterol), Lexapro (depression, anxiety), Plavix (blood clot prevention), Provigil (excessive sleepiness), Seroquel (schizophrenia, bipolar disorder), Singulair (asthma, allergy symptoms), TriCor (high cholesterol). Again, according to the report, these common brands could see price increases in the double digits before the cheaper ...
MonoSol Rx Secures 505(b)(2) Regulatory Pathway for Montelukast Sodium Oral Soluble Film - FierceBiotech


Montelukast is the active pharmaceutical ingredient in SINGULAIR, an asthma and allergy treatment that generated full-year worldwide sales of $4.7 billion in 2009 and faces patent expiration in 2012. Montelukast Sodium OSF dissolves within a few seconds when placed on the tongue to provide a complete dose of medication. SINGULAIR is currently approved in a ...
Drug Companies Pushing Up Prices In Patent-Ending Panic - The Consumerist


Reuters reports that prices in the US for certain brand-name drugs like Lipitor, Plavix, Singulair and 12 other of the biggest sellers rose by much higher rants in 2010 than they had in the previous five years. Their figures are based on data from Thomson Reuters MarketScan, which looked at the average cost of a daily dose as indicated in medical claims data. ...
The Herald-Sun - Achoo Bless you


She sees a doctor for her allergies, and takes the prescription medicine Singulair, which she said helps. For Brenda Nicholson of Durham, spring produces a foggy head, fatigue and "constant post-nasal drip." Her symptoms are bad in March and April, but usually disappear by summer. "I take some stuff over the counter, but you just have to wait it ...
Looking for a Washington, DC Singulair attorney? Get in touch with one of our Washington, DC Singulair attorneys now.

Pages:   1   2   3   4   5   6   ...   Next

Need A Singulair Attorney?

First Name Last Name Email Address State
Was Your Health Negatively Affected?

Please Describe the Injury

Your Friend's Email Address

Your Email Address

Type a Message (optional)


Looking for a Washington, DC Singulair attorney? Get in touch with one of our Washington, DC Singulair attorneys now.

 

Close (x)

Looking for an Attorney?


Please type your question:

Close (x)

logo Find Legal Help for Your Singulair Case - Submit Your Information Below

Do you need legal assistance with your Singulair case?
LegalView may be able to help.


Submit your information below for a free, no-cost evaluation.

We'll submit your information to one of our partner firms.
LegalView's partners represent clients throughout the United States, for a very wide range of legal issues. Submit your information now, to see if one of LegalView's partners can help!

* Indicates Required Fields

First name *
Last name *
Email Address *
Phone Number *
()  -

State *
Legal Issue * Unsafe Drugs: Singulair Change
Was There an Injury?
Please Describe The Injury

DISCLAIMER and STATEMENT OF NON-CONFIDENTIALITY

By submitting this form, you agree that completing the above is not intended to create an attorney-client relationship.

Disclosure

Legal WebTV Network LLC, LegalView.com, and LegalWebMedia.com are group advertising sponsored by the attorneys identified here. It is not a lawyer referral service. If you submit information on this website [more...]

Legal WebTV Network LLC, LegalView.com, and LegalWebMedia.com are group advertising sponsored by the attorneys identified here. It is not a lawyer referral service. If you submit information on this website, LegalWebMedia.com will submit your information to the law firms that pay for this group advertising and to respond to your requests for information concerning legal services in their assigned local areas. If there is no sponsoring firm in your state, your inquiry will be submitted to one of the sponsoring law firms on a predetermined, rotating basis. If the sponsoring law firm accepts your case, it will associate with licensed attorneys practicing in your state, if required; the sponsoring law firm may also contact other law firms to see if they may be able to assist.

The information provided by the LegalView.com and LegalWebMedia.com websites is for advertising and informational purposes and should not be considered as legal advice from the sponsoring attorneys. The websites contain general information and may not reflect current legal developments, verdicts, or settlements. LegalView.com contains information created by others or supplied through open forums; the sponsoring law firms are not responsible for the accuracy of this information. Any person viewing or receiving information from these websites should not act or refrain from acting on the basis of any such information without first seeking appropriate legal advice from an attorney in your area. Legal WebTV Network, LLC expressly disclaims any liability with respect to actions taken or not taken by the recipient based on any or all of the information or contents contained in these websites.

Any information sent to Legal WebTV Network LLC through this website is done using standard Web encryption techology. LegalView.com will exercise all reasonable care, within technological limits, to protect the confidentiality of any information submitted via Internet e-mail or through this website. By accessing this website, you may be seeking an attorney to represent you or legal advice. However, none of the sponsoring attorneys represent you yet.

The choice of a lawyer is an important decision and should not be based solely upon advertisements.

Any transmission of information, whether via Internet e-mail or through the website, is solely for evaluation purposes by the sponsoring law firms and their associates. The transmission of any information to any attorney sponsoring advertising on LegalView.com or LegalWebMedia.com does not create an attorney-client relationship between the sender and any recipient. An attorney-client relationship can only be created by a written, signed-fee agreement entered into with an attorney. The sponsoring attorneys will treat your information as a confidential communication for the purpose of obtaining legal services or legal advice.

For more information about the sponsoring law firms, please click here.

This form is secure and encrypted. More information about secure forms and your privacy here.